![Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States | Science | AAAS Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States | Science | AAAS](https://www.science.org/do/10.1126/science.abi6931/abs/Vaccine_waste_1280x720.jpg)
Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States | Science | AAAS
![Frontiers | Extension and Severity of Self-Reported Side Effects of Seven COVID-19 Vaccines in Mexican Population Frontiers | Extension and Severity of Self-Reported Side Effects of Seven COVID-19 Vaccines in Mexican Population](https://www.frontiersin.org/files/Articles/834744/fpubh-10-834744-HTML-r1/image_m/fpubh-10-834744-g001.jpg)
Frontiers | Extension and Severity of Self-Reported Side Effects of Seven COVID-19 Vaccines in Mexican Population
![Vaccines | Free Full-Text | Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy Vaccines | Free Full-Text | Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy](https://www.mdpi.com/vaccines/vaccines-10-00539/article_deploy/html/images/vaccines-10-00539-g001.png)
Vaccines | Free Full-Text | Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy
![Marion County Public Health Department will offer COVID vaccines for kids 5 and older beginning Thursday Marion County Public Health Department will offer COVID vaccines for kids 5 and older beginning Thursday](https://www.wfyi.org/files/wfyi/articles/original/ap21307727486453.jpg)
Marion County Public Health Department will offer COVID vaccines for kids 5 and older beginning Thursday
![Booster Shots and Additional Doses for COVID-19 Vaccines — What You Need to Know | Johns Hopkins Medicine Booster Shots and Additional Doses for COVID-19 Vaccines — What You Need to Know | Johns Hopkins Medicine](https://www.cdc.gov/vaccines/covid-19/images/COVID19-vaccination-schedule-immunocompromised.png)
Booster Shots and Additional Doses for COVID-19 Vaccines — What You Need to Know | Johns Hopkins Medicine
![Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7018e1_EffectivenessOlderAdults_IMAGE_28Apr21_1200x675.jpg)
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR
![Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet](https://www.thelancet.com/cms/attachment/caf9bf39-ae54-4e4f-a650-c7d3a3b705f9/gr1.jpg)
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
![3-shot combo? Pfizer, BioNTech roll COVID-19 booster trial as real-world data back first vaccine | Fierce Pharma 3-shot combo? Pfizer, BioNTech roll COVID-19 booster trial as real-world data back first vaccine | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1614266711/Screen%20Shot%202021-01-04%20at%2010.38.41%20AM.png/Screen%20Shot%202021-01-04%20at%2010.38.41%20AM.png?VersionId=897MH0N.8FbNpmbL4IheurvVYSoHHb2j)